CK
AMPE

Carnick & Kubik’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Carnick & Kubik’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$330K Hold
489
– – 0.1% 253
2015
Q4 		$513K Hold
489
– – 0.33% 96
2015
Q3 		$424K Buy
+489
New +$409K 0.3% 114

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
FPCP
Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CP
Camelot Portfolios Maumee, Ohio $143M AUM 14.82% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return

Carnick & Kubik's AMPE Position: Q1 2016 in Review

Carnick & Kubik held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q1 2016 at 489 shares worth $330K. The position accounts for 0.1% of the portfolio, ranked #253.

Carnick & Kubik first reported a position in AMPE in Q3 2015 and has held it in 3 quarters since. The position peaked at $513K in Q4 2015. 57 funds tracked by Wall St. Rank hold AMPE as of Q1 2016.

  • Carnick & Kubik held 489 shares of Ampio Pharmaceuticals Inc. worth $330K as of Q1 2016.
  • Carnick & Kubik left its Ampio Pharmaceuticals Inc. share count unchanged in Q1 2016.
  • Ampio Pharmaceuticals Inc. made up 0.1% of Carnick & Kubik's portfolio in Q1 2016, its #253 holding.
  • Carnick & Kubik first reported a position in Ampio Pharmaceuticals Inc. in Q3 2015 and has held it in 3 quarters since.
  • Carnick & Kubik's Ampio Pharmaceuticals Inc. position peaked at $513K in Q4 2015.
  • 57 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.